Contemporary management of coronary heart disease

Coronary heart disease remains the leading cause of mortality in the UK. This review focuses on the contemporary management of patients with acute coronary syndromes and those with stable angina, including the role of primary percutaneous coronary intervention versus fibrinolytic therapy in a UK set...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of the Royal College of Physicians of Edinburgh 2010-03, Vol.40 (1), p.44-48
1. Verfasser:	Menown, IBA
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - diagnosis Acute Coronary Syndrome - therapy Administration, Oral Angina Pectoris - diagnosis Angina Pectoris - therapy Angioplasty, Balloon, Coronary Anticoagulants - administration & dosage Anticoagulants - therapeutic use Aspirin - administration & dosage Aspirin - therapeutic use Coronary Disease - diagnosis Coronary Disease - drug therapy Coronary Disease - epidemiology Coronary Disease - mortality Coronary Disease - prevention & control Coronary Disease - therapy Electrocardiography Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - therapeutic use Humans Male Middle Aged Myocardial Infarction - diagnosis Myocardial Infarction - drug therapy Myocardial Infarction - therapy Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - therapeutic use Practice Guidelines as Topic Purinergic P2Y Receptor Agonists - administration & dosage Purinergic P2Y Receptor Agonists - therapeutic use Randomized Controlled Trials as Topic Registries Secondary Prevention Ticlopidine - administration & dosage Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Time Factors United Kingdom - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Coronary heart disease remains the leading cause of mortality in the UK. This review focuses on the contemporary management of patients with acute coronary syndromes and those with stable angina, including the role of primary percutaneous coronary intervention versus fibrinolytic therapy in a UK setting, current and emerging antiplatelet and anticoagulant therapies and the latest guidance on secondary prevention/lifestyle modification.
ISSN:	1478-2715 2042-8189
DOI:	10.4997/JRCPE.2010.122